Date Posted – 26 March 2021 Australia’s Minister for Industry, Science and Technology Karen Andrews visited Planet Innovation (PI) to officially open a new 1,000m2 medtech manufacturing wing in our Melbourne facility. The new wing is part of PI’s…
Date Posted – 22 March 2021 CoSec was acquired by international corporate services provider Acclime in a strategic move by both companies to expand operations internationally. Acclime has a strong and growing presence in nine key Asian jurisdictions…
Date posted – 17 March 2021 Media Release date – 3 March 2021 Research aimed at solving Australia’s greatest challenges will be made increasingly accessible as part of a shift towards ‘Open Access’ models at the national science…
Date posted – 17 March 2021 ANDHealth last week announced a joint effort with the Anthem Digital Incubator to facilitate and accelerate US market access and uptake for Australian digital health companies and their products and services. Anthem,…
Date posted – 9 March 2021 The addition of ERA Consulting allows PharmaLex to further expand its geographic footprint as well as strengthens its biopharma capabilities Frankfurt, Germany – February 24, 2021: PharmaLex Group, a leading provider of…
Date posted – 8 March 2021 First patented product to enter clinic within two years Cartherics Pty Ltd (Cartherics) announced today the grant of a European patent entitled “Genetically modified cells and uses thereof”. The patent covers aspects…
Date posted – 4 March 2021 The 2021 QS World University Rankings by Subject, released today, ranked Monash University number two in the world for Pharmacy and Pharmacology for the second year running. Pharmacy and Pharmacology remains Monash’s…
Date posted – 4 March 2021 The Australian Lung Health Initiative (ALHI) is pleased to announce it has been granted $28.9 million in funding from the Australian Federal Government’s Medical Research Future Fund (MRFF) Frontier Health and Medical…
Date posted – 26 February 2021 Researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) and PureTech Health (LSE: PRTC, Nasdaq: PRTC) have developed a novel technology platform that directly targets gut lymphatics and has great potential to…
16 February 2021 VivaZome Therapeutics Pty Ltd (“VivaZome”) and La Trobe University today announced that they have entered into a new collaborative research project focussed on developing novel exosome therapeutics. Under the collaborative arrangement, VivaZome scientists will work…
12 February 2021 • Kymriah® (tisagenlecleucel)[pronounced kim-RY-uh], a chimeric antigen receptor T cell (CAR-T) one-time treatment, will be the first commercially approved CAR-T therapy to be manufactured in Australia • Providing manufacturing capabilities in Australia will help reduce…
12 February 2021 Biointelect has made several new appointments to its Sydney and Melbourne-based teams as it experiences strong growth across all its three main consulting workstreams: R&D strategy and planning, biotech commercialisation and strategic market access, health…